SCHEMBL15904306

SCHEMBL15904306

CC(CCN(C)[C]=O)CC(=O)O

nearest known ligand 0.39

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BHMT Q93088 1/20 0.39
ALDH1A1 P00352 1/20 0.30
SLC22A6 Q4U2R8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15904353 0.80 BHMT (0.33) BHMTALDH1A1SLC22A6
SCHEMBL26234866 0.76 BHMT (0.41) BHMTALDH1A1SLC22A6
SCHEMBL270439 0.75
SCHEMBL9974590 0.73 BHMT (0.52) BHMTSLC22A6
SCHEMBL270952 0.72
SCHEMBL15903930 0.71 SLC22A6 (0.35) ALDH1A1SLC22A6
SCHEMBL1712694 0.70
SCHEMBL425046 0.69 BHMT (0.48) BHMTSLC22A6
SCHEMBL14360558 0.69 BHMT (0.48) BHMTSLC22A6
SCHEMBL15904350 0.69 GABRP (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2948450-A1 METALLOENZYME INHIBITOR COMPOUNDS Viamet Pharmaceuticals, Inc. (US) 2015-12-02 EP disclosed
WO-2014117090-A1 METALLOENZYME INHIBITOR COMPOUNDS VIAMET PHARMACEUTICALS, INC. (US) 2014-07-31 WO disclosed